Paediatric formulation of fosamprenavir approved in Europe
On 13 September, the EMEA issued a decision to extend the indication for fosamprenavir (Telzir) in combination with ritonavir to include adolescents and children of six years and older.
Telzir – EMEA European Public Assessment Report (includes full prescribing information)
Telzir – EMEA scientific opinion for approval PDF
Source: GSK press release.